Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
2,839
Views
2
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Impact of timing of nintedanib initiation among patients newly diagnosed with idiopathic pulmonary fibrosis

David Singera Boehringer Ingelheim, Ridgefield, CT, USA
,
Lindsay G. S. Bengtsonb Optum, Eden Prairie, MN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5370-4090
ORCID Icon,
Craig S. Conoscentia Boehringer Ingelheim, Ridgefield, CT, USA
,
Amy J. Andersonb Optum, Eden Prairie, MN, USA
,
Lee Brekkeb Optum, Eden Prairie, MN, USA
,
Sharash S. Shettya Boehringer Ingelheim, Ridgefield, CT, USA
&
Joao de Andradec Vanderbilt University Medical Center, Nashville, TN, USA
 show all
Pages 532-540 | Received 10 Jan 2022, Accepted 14 Mar 2022, Published online: 28 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.